April 1 (Reuters) - InMed Pharmaceuticals Inc IN.TO :
* INMED ANNOUNCES COMPLETION OF INITIAL PHASE 1 CLINICAL TRIAL OF INM-755 CBN CREAM IN HEALTHY SUBJECTS
* INMED PHARMACEUTICALS INC - ANTICIPATE REPORTING FINAL STUDY 755-101-HV RESULTS IN SECOND HALF OF CALENDAR 2020